Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0001193125-26-111286

Chief Medical Officer sold 3,150 shares at $48.26 ($152,019)

  • Chief Medical Officer acquired 8,125 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Patel Naimish · Chief Medical Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-03-14 Exercise or conversion : show line 1 in the form +8,125 16,293 D
2026-03-16 Sale : show line 2 in the form −3,150 $48.26 $152,019 13,143 D
Open-market sales · 3,150 sh · avg $48.26 · $152,019

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-03-14 Exercise or conversion : show line 3 in the form Restricted Stock Units −8,125 24,375 D
Loading xslF345X05/ownership.xml…